Safety and Efficacy of NNC 0129-0000-1003 for Treatment in Patients With Hemophilia A


Clinical Trial

Offered by: Nemours
Location: Orlando, FL

Trial Name

A Multinational Trial Evaluating Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Patients With Hemophilia A

What is the trial about?

Study of children with severe hemophilia A.

Who can participate?

Male patients at least 12 years old.

What is involved?

Participation in this study will last about 6 months in the on-demand arm and about 7 to 19 months in the prophylaxis arm. There will be a total of up to 12 study visits each lasting no more than 2 hours each. Complete physical exam, and blood/urine samples.

Contact Nemours Clinical Trials

Trial Name: A Multi-national Trial Evaluating Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Patients with Hemophilia A

Contact Information

(800) 354-5690
clinicaltrials@nemours.org